The JAK/STAT signal pathway is important in causing lymphoma. Researchers are studying how this pathway is changed in different types of lymphoma. They found that mutations in JAK kinase and STATs can lead to lymphoma. Abnormal JAK/STAT signaling can cause lymphoma to develop. Scientists are looking into using JAK/STAT inhibitors as a possible treatment for lymphoma.